- Home
- LVRO vs BDTX Comparison
LVRO vs BDTX Comparison
Compare LVRO & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVRO
- BDTX
- Stock Information
- Founded
- LVRO 2017
- BDTX 2014
- Country
- LVRO Brazil
- BDTX United States
- Employees
- LVRO N/A
- BDTX N/A
- Industry
- LVRO Blank Checks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LVRO Finance
- BDTX Health Care
- Exchange
- LVRO Nasdaq
- BDTX Nasdaq
- Market Cap
- LVRO 199.4M
- BDTX 181.4M
- IPO Year
- LVRO N/A
- BDTX 2020
- Fundamental
- Price
- LVRO $1.64
- BDTX $2.75
- Analyst Decision
- LVRO Sell
- BDTX Strong Buy
- Analyst Count
- LVRO 3
- BDTX 5
- Target Price
- LVRO $1.88
- BDTX $13.40
- AVG Volume (30 Days)
- LVRO 14.0K
- BDTX 854.1K
- Earning Date
- LVRO 10-31-2025
- BDTX 08-07-2025
- Dividend Yield
- LVRO N/A
- BDTX N/A
- EPS Growth
- LVRO N/A
- BDTX N/A
- EPS
- LVRO N/A
- BDTX 0.25
- Revenue
- LVRO $1,667,345,189.00
- BDTX $70,000,000.00
- Revenue This Year
- LVRO N/A
- BDTX N/A
- Revenue Next Year
- LVRO $11.45
- BDTX N/A
- P/E Ratio
- LVRO N/A
- BDTX $10.91
- Revenue Growth
- LVRO N/A
- BDTX N/A
- 52 Week Low
- LVRO $1.54
- BDTX $1.20
- 52 Week High
- LVRO $5.60
- BDTX $6.37
- Technical
- Relative Strength Index (RSI)
- LVRO 36.32
- BDTX 50.12
- Support Level
- LVRO $1.54
- BDTX $2.56
- Resistance Level
- LVRO $1.79
- BDTX $2.98
- Average True Range (ATR)
- LVRO 0.12
- BDTX 0.16
- MACD
- LVRO -0.02
- BDTX 0.01
- Stochastic Oscillator
- LVRO 14.49
- BDTX 57.83
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.